HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Rose Sheet

Executive Summary

National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods announces availability of two updated standardized in vitro cytotoxicity test method protocols for estimating acute oral systemic toxicity in rodents in Oct. 19 Federal Register notice. Protocols were recommended by Interagency Coordinating Committee on the Validation of Alternative Methods for determining starting doses for in vivo acute oral systemic tests to reduce the number of animals necessary in testing. NICEATM also requests data on chemicals and products tested for acute oral systemic toxicity and in vitro cytotoxicity using the standardized test method protocols. Data will be used to determine usefulness of cytotoxicity methods for estimating in vivo acute oral toxicity and investigate other methods to improve accuracy of in vitro assessments of acute systemic toxicity. Agency currently is accepting comments...

You may also be interested in...

NICEATM request

National Toxicology Program Interagency Center on Evaluation of Alternative Toxicological Methods requests nominations for scientists to sit on expert panel that will evaluate the validation status of two in vitro cytotoxicity assays for estimating in vivo acute oral toxicity in March 22 Federal Register 1notice. ICCVAM would consider the panel's conclusions in developing test method recommendations and performance standards, agency adds. Nominations should be sent to NICEATM Director William Stokes by May 6. NICEATM also is requesting data on standard in vivo acute oral toxicity and in vitro cytotoxicity tests. Agency announced the availability of the test protocols in October (2The Rose Sheet" Oct. 25, 2004, In Brief)...

Concerns About Eye Toxicity Could Limit GSK’s Myeloma Drug Potential

Company told more measures needed to limit damage to patients' eyes caused by antibody drug conjugate.

Stockwatch: Will Coronavirus Drug Developments Rescue The Sector’s Pricing Reputation?

Can the development of coronavirus vaccines and therapeutics reverse the demonization of the pharmaceutical sector brought about by drug price increases?




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts